TrialBritish journal of cancer2023

A real-world study of the first use of palbociclib for the treatment of advanced breast cancer within the UK National Health Service as part of the novel Ibrance® Patient Program.

Carlo Palmieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.